Delta, British Columbia, November 29, 2023 – Phyton Biotech LLC. proudly announces a significant milestone in its journey toward advancing pharmaceutical research and development. The Company is pleased to announce the receipt of its Controlled Substances Dealers License (CSDL) from Health Canada, effective November 2023. This pivotal license empowers Phyton Biotech to engage in groundbreaking work with psilocin and psilocybin.
Delta, British Columbia, November 29, 2023 – Phyton Biotech LLC. proudly announces a significant milestone in its journey toward advancing pharmaceutical research and development. The Company is pleased to announce the receipt of its Controlled Substances Dealers License (CSDL) from Health Canada, effective November 2023. This pivotal license empowers Phyton Biotech to engage in groundbreaking work with psilocin and psilocybin.
Phyton Biotech announces acquisition of Controlled Substances Dealers License from Health Canada
Phyton Biotech is headed to Food Ingredients Europe & Health Ingredients Europe in Frankfurt this Fall
Sustainable Production of Natural Substances by Plant Cell Cultivation
International Women’s Day
Phyton Biotech to Sponsor the Upcoming Economic Botany 2023 Conference
Phyton Biotech to Showcase Specialty Fermentation at CPhI Worldwide This November
Phyton Biotech to Showcase Specialty Fermentation at CPhI Worldwide This November
Phyton Biotech Continues to Expand its Team of Scientists